Escala Medical Awarded €5.5 Million EIC Funding to Revolutionize Pelvic Organ Prolapse Treatment
Summary
MISGAV, Israel, June 26, 2023 /PRNewswire/ -- Escala Medical Ltd., proudly announces its selection as a recipient of a 5.5 million in grant and equity investment from the European Innovation Council. FDA-cleared, Escalas revolutionary technology is now commercially available in the United States, marking a major milestone for the company.Current surgical treatment options for POP are invasive and principally suitable for advanced stage prolapse. Our game-changing device provides a long-awaited solution allowing early-stage treatment and significantly improving the quality of life for millions of women globally."Dr. It propels us forward in our mission to provide durable, incisionless treatments for patients suffering from pelvic organ prolapse, effectively enhancing their quality of life. Supported by Israeli, American, and British investors, and the Israel Innovation Authority, Escala is committed to offering its groundbreaking repair alternative for women at all stages of pelvic organ prolapse.